Does metabolic syndrome or its components associate with prostate cancer when diagnosed on biopsy?

Purpose: To investigate the association between metabolic syndrome and prostate cancer risk in Turkish men. Methods: We examined data from 220 patients with prostate cancer and 234 men in a control group with benign biopsy results, who had a serum prostate-specific antigen (PSA) level ⩾ 4 ng/ml, or...

Full description

Bibliographic Details
Main Authors: Onur Telli, Hasmet Sarici, Musa Ekici, Berat Cem Ozgur, Omer Gokhan Doluoglu, Muzaffer Eroglu, Tugba Akin Telli
Format: Article
Language:English
Published: SAGE Publishing 2015-03-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758834014560158